Today, we announced that the U.S. Food and Drug Administration (FDA) has accepted our resubmission of the RP1 Biologics License Application (BLA) for the treatment of advanced melanoma. Read more: https://lnkd.in/esRUTev5
About us
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
- Website
-
http://www.replimune.com
External link for Replimune
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Woburn, MA
- Type
- Public Company
- Founded
- 2015
Locations
-
Primary
Get directions
Woburn, MA 01801, US
Employees at Replimune
Updates
-
Replimune reposted this
Earlier this week, data from the IGNYTE trial of RP1 combined with nivolumab in anti-PD-1 failed melanoma was published online in the Journal of Clinical Oncology #melanoma Read the publication here: https://lnkd.in/erMkqfKq
-
Earlier this week, data from the IGNYTE trial of RP1 combined with nivolumab in anti-PD-1 failed melanoma was published online in the Journal of Clinical Oncology #melanoma Read the publication here: https://lnkd.in/erMkqfKq
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Today, we presented new analyses from the IGNYTE study of RP1 plus nivolumab in anti-PD-1 failed melanoma at the 2025 American Society of Clinical Oncology (ASCO) annual meeting. #melanoma #ASCO25 Read more: https://lnkd.in/e4rJAmNq
-
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
End of May! Reflecting on Melanoma Awareness Month and our Replimune team showing up to support the Melanoma Research Foundation Miles for Melanoma in Boston earlier this month. We were honored to be the local presenting sponsor and be part of the event which raised $173,457.46 to support the important work of the MRF. #melanoma
-
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.
-
Replimune is looking for motivated, talented individuals to join our team as we work to transform the treatment of cancer. We are passionate about advancing and establishing a new modality and are looking for others to help us in this mission as we ultimately work to deliver significant benefit to patients.